1. Home
  2. CDNA vs PRO Comparison

CDNA vs PRO Comparison

Compare CDNA & PRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • PRO
  • Stock Information
  • Founded
  • CDNA 1998
  • PRO 1985
  • Country
  • CDNA United States
  • PRO United States
  • Employees
  • CDNA N/A
  • PRO N/A
  • Industry
  • CDNA Medical Specialities
  • PRO EDP Services
  • Sector
  • CDNA Health Care
  • PRO Technology
  • Exchange
  • CDNA Nasdaq
  • PRO Nasdaq
  • Market Cap
  • CDNA 712.2M
  • PRO 761.5M
  • IPO Year
  • CDNA 2014
  • PRO 2007
  • Fundamental
  • Price
  • CDNA $13.82
  • PRO $15.51
  • Analyst Decision
  • CDNA Buy
  • PRO Strong Buy
  • Analyst Count
  • CDNA 7
  • PRO 9
  • Target Price
  • CDNA $27.67
  • PRO $26.89
  • AVG Volume (30 Days)
  • CDNA 1.5M
  • PRO 769.0K
  • Earning Date
  • CDNA 11-03-2025
  • PRO 10-28-2025
  • Dividend Yield
  • CDNA N/A
  • PRO N/A
  • EPS Growth
  • CDNA N/A
  • PRO N/A
  • EPS
  • CDNA 1.00
  • PRO N/A
  • Revenue
  • CDNA $340,826,000.00
  • PRO $342,708,000.00
  • Revenue This Year
  • CDNA $13.02
  • PRO $10.34
  • Revenue Next Year
  • CDNA $12.85
  • PRO $10.56
  • P/E Ratio
  • CDNA $13.85
  • PRO N/A
  • Revenue Growth
  • CDNA 14.72
  • PRO 7.96
  • 52 Week Low
  • CDNA $10.96
  • PRO $13.61
  • 52 Week High
  • CDNA $32.97
  • PRO $29.84
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 54.96
  • PRO 53.21
  • Support Level
  • CDNA $12.37
  • PRO $14.70
  • Resistance Level
  • CDNA $14.20
  • PRO $15.58
  • Average True Range (ATR)
  • CDNA 0.73
  • PRO 0.49
  • MACD
  • CDNA 0.27
  • PRO 0.08
  • Stochastic Oscillator
  • CDNA 87.02
  • PRO 77.36

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About PRO PROS Holdings Inc.

Pros Holdings Inc provides software solutions that optimize shopping and selling experiences for both business-to-business and business-to-consumer companies across industry verticals in more than nearly 80 countries. Its PROS Platform is designed to help businesses create, optimize and market available offers and handle orders through both first- and third-party digital channels. The firm generates key revenue form the United States of America, Germany, The rest of Europe, Africa, Asia-Pacific, and Middle East regions.

Share on Social Networks: